EUVIMED · CrossrefZeitschrift
Cancer Biology & Therapy
ISSN 1538-4047 · Informa UK Limited
Neueste Artikel
Downregulation of the lncRNA PGM5P4-AS1 predicts poor prognosis and drives breast cancer progression through miR-3664-5p/KLF9
The role of copper and cuproptosis in digestive system cancers: novel therapeutic strategies and mechanistic insights
The MYBL2-GTSE1 axis promotes laryngeal squamous cell carcinoma progression by regulating PI3K/AKT-dependent glycolytic reprogramming
Centromere protein I promotes hepatocellular carcinoma progression by activating PI3K/AKT/mTOR-CDK2 cascade
ULK1's role in cancer progression and its emerging therapeutic potential
NRF2 and mutant p53 separately regulate redox balance in esophageal squamous cell carcinoma through metabolic reprogramming
The Zα domain of ADAR1: emerging roles in cancer biology and evidence as a promising therapeutic target
GPRIN1 enhances gallbladder cancer progression and is associated with the CDK1 pathway
The role of ASF1B in disease pathogenesis and treatment: from histone chaperone to clinical target
RBBP5 drives cancer stem cell-like characteristics by suppressing the hippo signaling pathway through WNT5A downregulation in breast cancer
The role of carbonic anhydrases IX and XII in hypoxia-driven tumor adaptation and chemoresistance: an underexplored frontier for novel therapeutic strategies in ovarian cancer
Adaptive kinase signaling enables escape from small molecule inhibition in glioblastoma
The p16 isoform of CDKN2A inhibits ferroptosis to promote the progression of papillary thyroid carcinoma by influencing the p53/SLC7A11/GPX4 pathway
Long-term effects of neoadjuvant chemotherapy in variant histology locally advanced colon cancer: a propensity score-matched analysis
The RNA-binding protein ELAVL1 promotes Beclin1-mediated cellular autophagy and thus endometrial cancer development by affecting LncRNA-neat stability
Electrochemical biosensing in oncology: a review advancements and prospects for cancer diagnosis
MGAT4EP promotes tumor progression and serves as a prognostic marker for breast cancer
Silencing ZIC5 suppresses glycolysis and promotes disulfidptosis in lung adenocarcinoma cells
Definitive chemoradiotherapy combined with anti-PD-1 immunotherapy for inoperable esophageal squamous cell carcinoma: a multicenter real-world study
Lung cancer cell derived sEVs enhance the metastasis of non-small cell lung cancer via SNHG12/miR-326/SLC7A11 axis
Robust prediction of glioma prognosis by hypoxia-induced ferroptosis genes: VEGFA-XBP1 co-expression for salvage therapy
Lenvatinib promotes hepatocellular carcinoma pyroptosis by regulating GSDME palmitoylation
Dual role of CXCL10 in cancer progression: implications for immunotherapy and targeted treatment
Hypoxia-induced PYCR1 regulates glycolysis and histone lactylation to promote bladder cancer progression and metastasis via SLC6A14/Glutamine metabolism
Patient-derived organoids (PDOs) as a promising platform for personalized treatment of colorectal cancer: current applications and future challenges
Nuclear translocation of Cx43 promotes to CRC progression and associates with β-catenin accumulation
Red ginseng polysaccharide promotes ferroptosis in gastric cancer cells by inhibiting PI3K/Akt pathway through down-regulation of AQP3
The amino acid transporter SLC7A11 expression in breast cancer
Epigenetic silencing ZSCAN23 promotes pancreatic cancer growth by activating Wnt signaling
Hypoxia promotes non-small cell lung cancer cell stemness, migration, and invasion via promoting glycolysis by lactylation of SOX9
EUVIMED